Young biotech leader $IMCR with good VCP
Immunocore Holdings is a commercial-stage T cell receptor biotechnology company working to develop and commercialize transformative medicines for oncology, infectious diseases and autoimmune and inflammation diseases.
In a confirmed uptrend, yesterday signaled a good pivot buy where I placed an initial position.
I liked the volatility contraction pattern and the bullish divergence with the 10-day ROC prior to the breakout, and now I'll wait for the follow through action to add to the position.
Lets wait and see.
In a confirmed uptrend, yesterday signaled a good pivot buy where I placed an initial position.
I liked the volatility contraction pattern and the bullish divergence with the 10-day ROC prior to the breakout, and now I'll wait for the follow through action to add to the position.
Lets wait and see.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.